Report Detail
Radiation Therapy
- RnM3570738 |
- 12 March, 2020 |
- Global |
- 398 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Radiation is one of the most common treatments for cancer and may be delivered by a machine outside the body (external-beam radiation therapy), or it may be delivered by a radioactive material placed in the body near cancer cells (internal radiation therapy/ brachytherapy), or by systemic radiation therapy which uses radioactive substances, such as radioactive iodine, that travel in the blood to kill cancer cells. About half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Radiation therapy is sometimes given with curative intent. In such cases, radiation therapy may be used alone or in combination with surgery, chemotherapy, or both. It may also be given with palliative intent, which is not intended to cure; instead they relieve symptoms and reduce the suffering caused by cancer. For example, radiation given to the brain to shrink tumours formed from cancer cells that have spread to the brain from another part of the body. Radiation therapy kills cancer cells either by damaging DNA directly or creates charged particles (free radicals) within the cells that can in turn damage the DNA, but does not travel throughout the body as chemotherapy treatment does. But, it can cause side effects, damaging healthy cells and tissues surrounding the tumour cells, in turn can also damage the surrounding organs and it may also leads to develop a secondary cancer as a result of exposure to radiation. Today, major advances in radiation technology have made it more precise, leading to fewer side effects with the modern ways of giving radiation therapy and careful treatment planning aim to reduce the risk of these complications. The radiation therapy global market is expected to grow at mid single digit CAGR to reach 8,680.6 million by 2024.
The radiation therapy market is segmented based on their products, technology, end-users and geography. The radiation therapy market by products is segmented into external radiation therapy products, internal radiation therapy products and systemic radiation therapy products. The external radiation therapy products are further segmented into Linear accelerators (Linacs) and proton therapy systems. The internal radiation therapy product is further segmented into seeds, applicators & afterloaders, others (electronic brachytherapy & accessories) and systemic radiation therapy products are further segmented into alpha emitters and beta emitters. Based on technologies, the radiation therapy market is segmented into external radiation therapy technologies, internal radiation therapies and systemic radiation therapy technologies. External radiation therapy technologies are further segmented into Stereotactic radio surgery (SRS), Stereotactic body radiation therapy (SBRT), Image-guided radiation therapy (IGRT), Intensity-modulated radiation therapy (IMRT); Volumetric modulated arc therapy (VMAT), Intensity-modulated proton therapy (IMPT) and others. Internal radiation therapy technology is further segmented into High dose rate brachytherapy, low dose rate brachytherapy and others. Based on applications, radiation therapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, gastrointestinal cancer, lung cancer, brain cancer, head & neck cancer and others. Based on end-users, radiation therapy market is segmented into hospitals, radiation therapy centres, ambulatory surgical centres and others. Further the radiation therapy global market is separated by geographical regions into North America, Europe, Asia-pacific and Rest of the World. North America is further segmented into U.S. and Others. Europe is further segmented into Germany, Italy, France, and others. Asia-pacific region is further segmented into China, Japan, India and others and Rest of the world is further segmented into Brazil, Rest of Latin America and Middle East & Others.
1 EXECUTIVE SUMMARY 24
2 INTRODUCTION 29
- 2.1 KEY TAKEAWAYS 29
- 2.2 REPORT DESCRIPTION 30
- 2.3 MARKETS COVERED 31
- 2.4 STAKEHOLDERS 33
- 2.5 RESEARCH METHODOLOGY 33
- 2.5.1 MARKET SIZE ESTIMATION 35
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 37
- 2.5.3 SECONDARY SOURCES 38
- 2.5.4 PRIMARY SOURCES 39
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 39
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 40
- 2.5.7 ASSUMPTIONS 40
3 MARKET ANALYSIS 42
- 3.1 INTRODUCTION 42
- 3.2 MARKET SEGMENTATION 44
- 3.3 FACTORS INFLUENCING MARKET 46
- 3.4 MARKET DYNAMICS 47
- 3.4.1 DRIVERS AND OPPORTUNITIES 47
- 3.4.1.1 Growing prevalence of cancer cases 47
- 3.4.1.2 Adoption of unhealthy lifestyle 47
- 3.4.1.3 Technological advancements 48
- 3.4.1.4 Rising preference for non-invasive procedures of cancer treatment 49
- 3.4.1.5 Rapid rise in geriatric population 50
- 3.4.2 RESTRAINTS AND THREATS 50
- 3.4.2.1 Side effects associated with the radiation therapy 50
- 3.4.2.2 Lack of sufficient infrastructure and skilled technicians in low and middle income countries 51
- 3.4.2.3 Lack of awareness and understanding about radiation therapy’s importance 52
- 3.4.2.4 High cost of radiation therapy devices 52
- 3.4.2.5 Stringent regulatory requirements 53
- 3.4.1 DRIVERS AND OPPORTUNITIES 47
- 3.5 REGULATORY AFFAIRS 54
- 3.5.1 U.S. 54
- 3.5.2 EUROPE 55
- 3.5.3 CHINA 56
- 3.5.4 INDIA 57
- 3.5.5 JAPAN 58
- 3.6 REIMBURSEMENT SCENARIO 59
- 3.6.1 REIMBURSEMENT TABLE 60
- 3.7 CLINICAL TRIAL DATA 63
- 3.8 PATENT TRENDS 73
- 3.9 TECHNOLOGICAL ADVANCEMENTS 74
- 3.9.1 INTRODUCTION 74
- 3.9.1.1 Advancements in linear accelerator technology 75
- 3.9.1.2 MRI-guided radiation therapy 76
- 3.9.1.3 Proton therapy 76
- 3.9.1 INTRODUCTION 74
- 3.10 FUNDING SCENARIO 78
- 3.11 PORTER’S FIVE FORCE ANALYSIS 83
- 3.11.1 THREAT OF NEW ENTRANTS 84
- 3.11.2 THREAT OF SUBSTITUTES 84
- 3.11.3 BARGAINING POWER OF SUPPLIERS 85
- 3.11.4 BARGAINING POWER OF BUYERS 86
- 3.11.5 RIVALRY AMONG EXISTING COMPETITORS 86
- 3.12 SUPPLY CHAIN ANALYSIS 87
- 3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 90
- 3.13.1 MARKET SHARE ANALYSIS OF LINAC BY MAJOR PLAYERS 93
- 3.13.2 LINAC INSTALLED BASE GLOBAL MARKET SHARE, BY REGION 95
- 3.13.3 MARKET SHARE ANALYSIS OF PROTON THERAPY SYSTEMS BY MAJOR PLAYERS 97
- 3.13.4 MARKET SHARE ANALYSIS OF BRACHYTHERAPY BY MAJOR PLAYERS 99
- 3.13.5 BRACHYTHERAPY INSTALLED BASE GLOBAL MARKET SHARE, BY
REGION 101
- 3.13.6 MARKET SHARE ANALYSIS OF ELECTRONIC BRACHYTHERAPY, BY
MAJOR PLAYERS 102
4 RADIATION THERAPY GLOBAL MARKET, BY PRODUCT TYPE 104
- 4.1 INTRODUCTION 104
- 4.2 EXTERNAL BEAM RADIATION THERAPY 107
- 4.2.1 LINEAR ACCELERATORS (LINACS) 110
- 4.2.2 PROTON THERAPY SYSTEMS 113
- 4.3 INTERNAL RADIATION THERAPY 117
- 4.3.1 SEEDS 122
- 4.3.2 APPLICATORS & AFTERLOADERS 123
- 4.3.3 OTHERS (ELECTRONIC BRACHYTHERAPY & ACCESSORIES) 126
- 4.4 SYSTEMIC RADIATION THERAPY 128
- 4.4.1 ALPHA EMITTERS 132
- 4.4.2 BETA EMITTERS 133
5 RADIATION THERAPY GLOBAL MARKET, BY TECHNOLOGY 136
- 5.1 INTRODUCTION 136
- 5.2 EXTERNAL RADIATION THERAPY 139
- 5.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT) 141
- 5.2.2 INTENSITY-MODULATED RADIATION THERAPY (IMRT) 143
- 5.2.3 VOLUMETRIC MODULATED ARC THERAPY (VMAT) 145
- 5.2.4 STEREOTACTIC BODY RADIATION THERAPY (SBRT) 147
- 5.2.5 STEREOTACTIC RADIOSURGERY (SRS) 149
- 5.2.6 INTENSITY MODULATED PROTON THERAPY (IMPT) 151
- 5.2.7 OTHER EXTERNAL RADIATION THERAPIES 152
- 5.3 INTERNAL RADIATION THERAPY 155
- 5.3.1 HIGH DOSE RATE (HDR) BRACHYTHERAPY 159
- 5.3.2 LOW DOSE RATE (LDR) BRACHYTHERAPY 160
- 5.3.3 OTHER INTERNAL RADIATION THERAPIES 162
- 5.4 SYSTEMIC RADIATION THERAPY 165
6 RADIATION THERAPY GLOBAL MARKET BY APPLICATIONS 167
- 6.1 INTRODUCTION 167
- 6.1.1 PROSTATE CANCER 170
- 6.1.2 GYNAECOLOGY CANCERS 172
- 6.1.3 BREAST CANCER 174
- 6.1.4 HEAD & NECK CANCER 176
- 6.1.5 LUNG CANCER 178
- 6.1.6 BRAIN CANCER 180
- 6.1.7 GASTROINTESTINAL CANCER 182
- 6.1.8 OTHERS 184
7 RADIATION THERAPY GLOBAL MARKET, BY END-USERS 188
- 7.1 INTRODUCTION 188
- 7.2 HOSPITALS 190
- 7.3 AMBULATORY SURGICAL CENTRES 192
- 7.4 RADIATION THERAPY SPECIALITY CENTRES 194
- 7.5 OTHERS 195
8 REGIONAL ANALYSIS 198
- 8.1 INTRODUCTION 198
- 8.2 NORTH AMERICA 201
- 8.2.1 U.S. 213
- 8.2.2 OTHERS 217
- 8.3 EUROPE 219
- 8.3.1 GERMANY 233
- 8.3.2 ITALY 235
- 8.3.3 FRANCE 239
- 8.3.4 OTHERS 242
- 8.4 ASIA PACIFIC (APAC) 246
- 8.4.1 CHINA 258
- 8.4.2 JAPAN 261
- 8.4.3 INDIA 265
- 8.4.4 OTHERS 268
- 8.5 REST OF THE WORLD (ROW) 272
- 8.5.1 BRAZIL 284
- 8.5.2 REST OF LATIN AMERICA 287
- 8.5.3 MIDDLE EAST AND OTHERS 290
9 COMPETITIVE LANDSCAPE 293
- 9.1 INTRODUCTION 293
- 9.2 AGREEMENTS, PARTNERSHIPS AND COLLABORATIONS 294
- 9.3 APPROVALS 302
- 9.4 NEW PRODUCT LAUNCH 307
- 9.5 ACQUISITIONS 309
- 9.6 OTHER DEVELOPMENTS 311
10 MAJOR COMPANIES 314
- 10.1 ACCURAY, INCORPORATED 314
- 10.1.1 OVERVIEW 314
- 10.1.2 FINANCIALS 315
- 10.1.3 PRODUCT PORTFOLIO 318
- 10.1.4 KEY DEVELOPMENTS 318
- 10.1.5 BUSINESS STRATEGY 319
- 10.1.6 SWOT ANALYSIS 320
- 10.2 BAYER AG 321
- 10.2.1 OVERVIEW 321
- 10.2.2 FINANCIALS 322
- 10.2.3 PRODUCT PORTFOLIO 324
- 10.2.4 KEY DEVELOPMENTS 324
- 10.2.5 BUSINESS STRATEGY 325
- 10.2.6 SWOT ANALYSIS 326
- 10.3 BRAINLAB AG 327
- 10.3.1 OVERVIEW 327
- 10.3.2 FINANCIALS 328
- 10.3.3 PRODUCT PORTFOLIO 328
- 10.3.4 KEY DEVELOPMENTS 328
- 10.3.5 BUSINESS STRATEGY 329
- 10.3.6 SWOT ANALYSIS 330
- 10.4 C.R.BARD INC. 331
- 10.4.1 OVERVIEW 331
- 10.4.2 FINANCIALS 332
- 10.4.3 PRODUCT PORTFOLIO 334
- 10.4.4 KEY DEVELOPMENTS 335
- 10.4.5 BUSINESS STRATEGY 335
- 10.4.6 SWOT ANALYSIS 336
- 10.5 CARL ZEISS MEDITEC AG 337
- 10.5.1 OVERVIEW 337
- 10.5.2 FINANCIALS 338
- 10.5.3 PRODUCT PORTFOLIO 340
- 10.5.4 KEY DEVELOPMENTS 341
- 10.5.5 BUSINESS STRATEGY 341
- 10.5.6 SWOT ANALYSIS 342
- 10.6 ECKERT & ZIEGLER BIBEG 343
- 10.6.1 OVERVIEW 343
- 10.6.2 FINANCIALS 344
- 10.6.3 PRODUCT PORTFOLIO 346
- 10.6.4 KEY DEVELOPMENTS 346
- 10.6.5 BUSINESS STRATEGY 347
- 10.6.6 SWOT ANALYSIS 348
- 10.7 ELEKTA AB 349
- 10.7.1 OVERVIEW 349
- 10.7.2 FINANCIALS 350
- 10.7.3 PRODUCT PORTFOLIO 353
- 10.7.4 KEY DEVELOPMENTS 354
- 10.7.5 BUSINESS STRATEGY 355
- 10.7.6 SWOT ANALYSIS 356
- 10.8 HITACHI MEDICAL CORPORATION 357
- 10.8.1 OVERVIEW 357
- 10.8.2 FINANCIALS 358
- 10.8.3 PRODUCT PORTFOLIO 361
- 10.8.4 KEY DEVELOPMENTS 361
- 10.8.5 BUSINESS STRATEGY 363
- 10.8.6 SWOT ANALYSIS 364
- 10.9 IBA (ION BEAM APPLICATIONS S.A.) 365
- 10.9.1 OVERVIEW 365
- 10.9.2 FINANCIALS 366
- 10.9.3 PRODUCT PORTFOLIO 368
- 10.9.4 KEY DEVELOPMENTS 369
- 10.9.5 BUSINESS STRATEGY 371
- 10.9.6 SWOT ANALYSIS 372
- 10.10 MEVION MEDICAL SYSYTEMS. 373
- 10.10.1 OVERVIEW 373
- 10.10.2 FINANCIALS 374
- 10.10.3 PRODUCT PORTFOLIO 374
- 10.10.4 KEY DEVELOPMENTS 374
- 10.10.5 BUSINESS STRATEGY 376
- 10.10.6 SWOT ANALYSIS 377
- 10.11 RAYSEARCH LABORATORIES INC., 378
- 10.11.1 OVERVIEW 378
- 10.11.2 FINANCIALS 379
- 10.11.3 PRODUCT PORTFOLIO 381
- 10.11.4 KEY DEVELOPMENTS 381
- 10.11.5 BUSINESS STRATEGY 384
- 10.11.6 SWOT ANALYSIS 385
- 10.12 VARIAN MEDICAL SYSTEMS, INC. 386
- 10.12.1 OVERVIEW 386
- 10.12.2 FINANCIALS 387
- 10.12.3 PRODUCT PORTFOLIO 389
- 10.12.4 KEY DEVELOPMENTS 390
- 10.12.5 BUSINESS STRATEGY 392
- 10.12.6 SWOT ANALYSIS 393
- 10.13 VIEWRAY, INC., 394
- 10.13.1 OVERVIEW 394
- 10.13.2 FINANCIALS 394
- 10.13.3 PRODUCT PORTFOLIO 395
- 10.13.4 KEY DEVELOPMENTS 395
- 10.13.5 BUSINESS STRATEGY 396
Summary:
Get latest Market Research Reports on Radiation Therapy . Industry analysis & Market Report on Radiation Therapy is a syndicated market report, published as Radiation Therapy . It is complete Research Study and Industry Analysis of Radiation Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
